239 related articles for article (PubMed ID: 9657094)
1. Increased cerebrovascular resistance in cirrhotic patients with ascites.
Guevara M; Bru C; Ginès P; Fernández-Esparrach G; Sort P; Bataller R; Jiménez W; Arroyo V; Rodés
Hepatology; 1998 Jul; 28(1):39-44. PubMed ID: 9657094
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
[TBL] [Abstract][Full Text] [Related]
3. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction.
Maroto A; Ginès P; Arroyo V; Ginès A; Saló J; Clària J; Jiménez W; Bru C; Rivera F; Rodés J
Hepatology; 1993 May; 17(5):788-93. PubMed ID: 8491446
[TBL] [Abstract][Full Text] [Related]
4. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
[TBL] [Abstract][Full Text] [Related]
5. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
Wong F; Logan A; Blendis L
Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
[TBL] [Abstract][Full Text] [Related]
6. Effect of dipyridamole on kidney function in cirrhosis.
Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
[TBL] [Abstract][Full Text] [Related]
7. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of ascites in cirrhosis and portal hypertension.
Heneghan MA; Harrison PM
Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
[TBL] [Abstract][Full Text] [Related]
9. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
10. Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index.
Cazzaniga M; Salerno F; Visentin S; Cirello I; Donarini C; Cugno M
Liver Int; 2008 Dec; 28(10):1396-401. PubMed ID: 18673435
[TBL] [Abstract][Full Text] [Related]
11. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites.
Trevisani F; Sica G; Mainquà P; Santese G; De Notariis S; Caraceni P; Domenicali M; Zacà F; Grazi GL; Mazziotti A; Cavallari A; Bernardi M
Hepatology; 1999 Dec; 30(6):1387-92. PubMed ID: 10573516
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular responsiveness after isotonic exercise in cirrhotic patients: study on sympathoadrenergic and renin-angiotensin systems.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Sakaki M; Shigemori H; Nakayama M; Tanikawa K; Iwao J
Am J Gastroenterol; 1994 Jul; 89(7):1043-6. PubMed ID: 8017363
[TBL] [Abstract][Full Text] [Related]
13. Renal haemodynamics in patients with liver cirrhosis assessed by colour ultrasonography.
Wang Y; Liu LP; Bai WY; Wen SB; Dan HJ; Luan YY; Zeng MX; Hu B
J Int Med Res; 2011; 39(1):249-55. PubMed ID: 21672328
[TBL] [Abstract][Full Text] [Related]
14. [The renin-angiotensin-aldosterone system in liver cirrhosis].
Giudici Cipriani A; Folco U; Colombo P; Menardo G; Cattana A; Barbetti V; Rembado R; Marenco G
Minerva Med; 1990; 81(1-2):45-53. PubMed ID: 2314615
[TBL] [Abstract][Full Text] [Related]
15. Relationships between hemodynamic alterations and Child-Pugh Score in patients with cirrhosis.
Dincer D; Besisk F; Demirkol O; Demir K; Kaymakoglu S; Cakaloglu Y; Okten A
Hepatogastroenterology; 2005; 52(65):1521-5. PubMed ID: 16201110
[TBL] [Abstract][Full Text] [Related]
16. Ascites in liver diseases.
Gentilini P; Laffi G
Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase inhibition does not improve renal function in cirrhotic patients with ascites.
Thiesson HC; Skøtt O; Jespersen B; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2003 Jan; 98(1):180-6. PubMed ID: 12526955
[TBL] [Abstract][Full Text] [Related]
18. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
[TBL] [Abstract][Full Text] [Related]
19. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
[TBL] [Abstract][Full Text] [Related]
20. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.
Mindikoglu AL; Dowling TC; Wong-You-Cheong JJ; Christenson RH; Magder LS; Hutson WR; Seliger SL; Weir MR
Am J Nephrol; 2014; 39(6):543-52. PubMed ID: 24943131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
